Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’
Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’
Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’
Submitted by
admin
on August 14, 2009 - 9:24am
Source:
WSJ Online
News Tags:
Amgen
FDA
denosumab
Headline:
Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’
Do Not Allow Advertisers to Use My Personal information
